The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China

NCT06728345 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Migraine
Migraine Prophylaxis

Interventions

DRUG: Rimegepant

Sponsor

The First Affiliated Hospital of Soochow University